Biotechnology

AXA Investment Managers is to hand its Health and Biotech funds to Mark Hargraves and Bruno Grandsard on a temporary basis.

AXA Framlington is to hand Deane Donnigan's Biotech fund to Gemma Game following her shock departure.

IBT's David Pinniger explains how the UK Budget has enhanced the investment story behind biotechnology.

IBT's David Pinniger explains why investors looking for growth should consider the biotech space.